KEVIN TAWZER: Open Payments
NPI 1740735992 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$435 in 19 payments from 13 companies in 2025. Trend: 2023 $1,178 · 2024 $1,294 · 2025 $435
Food & beverage: $435
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 2 | $61 |
| Regeneron Healthcare Solutions, Inc. | 2 | $59 |
| ABBVIE INC. | 3 | $53 |
| Janssen Biotech, Inc. | 2 | $53 |
| UCB, Inc. | 2 | $42 |
| LEO Pharma Inc. | 1 | $31 |
| Almirall LLC | 1 | $25 |
| PFIZER INC. | 1 | $23 |
| Organon LLC | 1 | $23 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
Products named: DUPIXENT, SKYRIZI, TREMFYA, Bimzelx, ANZUPGO, Seysara, LITFULO, COSENTYX.
Industry payments across TN — which companies pay providers there.
